- Home
- NNNN vs MAN Comparison
NNNN vs MAN Comparison
Compare NNNN & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- MAN
- Stock Information
- Founded
- NNNN 2021
- MAN 1948
- Country
- NNNN Germany
- MAN United States
- Employees
- NNNN N/A
- MAN N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MAN Professional Services
- Sector
- NNNN Health Care
- MAN Consumer Discretionary
- Exchange
- NNNN Nasdaq
- MAN Nasdaq
- Market Cap
- NNNN 2.2B
- MAN 2.1B
- IPO Year
- NNNN 2025
- MAN 1988
- Fundamental
- Price
- NNNN $43.04
- MAN $37.79
- Analyst Decision
- NNNN
- MAN Hold
- Analyst Count
- NNNN 0
- MAN 5
- Target Price
- NNNN N/A
- MAN $48.40
- AVG Volume (30 Days)
- NNNN 49.3K
- MAN 808.4K
- Earning Date
- NNNN 01-01-0001
- MAN 10-16-2025
- Dividend Yield
- NNNN N/A
- MAN 5.84%
- EPS Growth
- NNNN N/A
- MAN N/A
- EPS
- NNNN 0.06
- MAN N/A
- Revenue
- NNNN $8,185,146.00
- MAN $17,539,500,000.00
- Revenue This Year
- NNNN N/A
- MAN $0.74
- Revenue Next Year
- NNNN N/A
- MAN $3.40
- P/E Ratio
- NNNN $802.78
- MAN N/A
- Revenue Growth
- NNNN 21.95
- MAN N/A
- 52 Week Low
- NNNN $5.18
- MAN $37.57
- 52 Week High
- NNNN $55.65
- MAN $75.57
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- MAN 38.88
- Support Level
- NNNN N/A
- MAN $37.57
- Resistance Level
- NNNN N/A
- MAN $39.69
- Average True Range (ATR)
- NNNN 0.00
- MAN 1.38
- MACD
- NNNN 0.00
- MAN -0.29
- Stochastic Oscillator
- NNNN 0.00
- MAN 5.40
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.